L. Simkens

发表

Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study.

G. Beets, R. Verhoeven, F. W. Kloppenberg, 2021, European journal of cancer.

Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.

C. Punt, M. Koopman, L. Simkens, 2008, Clinical colorectal cancer.

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

C. Punt, M. Koopman, E. van Werkhoven, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Optimal duration of systemic treatment in metastatic colorectal cancer

C. Punt, M. Koopman, L. Simkens, 2014, Current opinion in oncology.

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.

R. Bleichrodt, V. Lemmens, M. Koopman, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with capecitabine + bevacizumab versus observation after induction treatment with chemotherapy + bevacizumab in metastatic colorectal cancer (mCRC).

C. Punt, M. Koopman, A. May, 2014 .

Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study

C. Punt, H. Guchelaar, H. Gelderblom, 2014, PloS one.

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.

C. Punt, M. Koopman, S. Teerenstra, 2011, European journal of cancer.

Aging Blunts Remodeling of the Uterine Artery During Murine Pregnancy

L. Simkens, G. V. van Eys, J. D. De Mey, 2004, The Journal of the Society for Gynecologic Investigation: JSGI.

Systemic treatment: maintenance compared with holiday.

C. Punt, M. Koopman, L. Simkens, 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

C. Marijnen, J. Burger, M. Berbée, 2022, BMC cancer.

Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer.

M. V. van Oijen, C. Punt, M. Koopman, 2019, Patient education and counseling.

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group.

C. Punt, W. Kok, M. Koopman, 2017, European journal of cancer.

Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC): The phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG).

O. Dalesio, C. Punt, M. Koopman, 2013 .

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group.

C. Punt, M. Koopman, E. van Werkhoven, 2019, Clinical colorectal cancer.

The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab.

I. Nagtegaal, C. Punt, L. Terstappen, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care

P. Siersema, C. Punt, G. Beets, 2021, Scientific Reports.

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

P. Peeters, C. Punt, P. D. de Jong, 2019, Cancer medicine.

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

P. Peeters, C. Punt, P. D. de Jong, 2019, Journal of cachexia, sarcopenia and muscle.

Transanal total mesorectal excision and low anterior resection syndrome.

E. Verdaasdonk, G. Beets, J. Ijzermans, 2021, The British journal of surgery.

A propensity score‐matched analysis of oncological outcome after systemic therapy for stage IV colorectal cancer: Impact of synchronous ovarian metastases

L. Simkens, R. Roumen, I. Hingh, 2022, International journal of cancer.

Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study

L. Simkens, R. Roumen, F. V. van Erning, 2022, Journal of Cancer Research and Clinical Oncology.

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer

Leon W. M. M. Terstappen, Gerhardt Attard, C. Punt, 2013, PloS one.

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

C. Punt, M. Koopman, A. May, 2015, The Lancet.

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

C. Punt, H. Verheul, M. Koopman, 2020, British Journal of Cancer.